Device Trial Radar · NCT03206502
Embrace: Seizure Characterization
Last checked: Nov 19, 2026Latest source record: Aug 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100,000
Planned (sponsor's estimate)
Start
May 2016
Primary completion
May 2026
Study completion May 2026
Sponsor
- Lead sponsor
- Empatica, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 2, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 1 year, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is intended to characterize sleep, stress, and seizures in daily life with the Empatica Embrace watch and smartphone-based diary-alert system. The primary study objective is to collect and validate biometric signals from epilepsy patients using the Empatica Embrace watch and compare them to ictal events captured from human (patient and caregiver) reports.
Conditions
- Epilepsy
Interventions
Embrace + Alert AppDevice
Participants will wear an Embrace smartwatch to collect data, and will provide survey/diary information on the occurrence of seizures. The device sends data to the Alert app, which issues either true detections or false alarms when it detects a possible convulsive seizure. Participants are asked to either cancel (in real time) or mark (at a later time) all false alarms using the Alert app.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity of the GTCS detection of the Embrace + Alert appTime frame: The primary outcome is assessed continuously over the trial period (each new seizure is counted and summed for each person; the average time period is 6 months)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.